Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Особенности клинического течения и прогноз больных неходжкинской лимфомой с первичной локализацией в яичке
Особенности клинического течения и прогноз больных неходжкинской лимфомой с первичной локализацией в яичке
Г.С.Тумян, А.М.Ковригина, О.Л.Тимофеева, Н.А.Пробатова, Е.Н.Шолохова, Н.Н.Тупицын, И.В.Поддубная, Д.Ш.Османов. Особенности клинического течения и прогноз больных неходжкинской лимфомой с первичной локализацией в яичке. Онкология. 2006; 4: 22-26.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Moller MB, d`Amore F, Chistensen BE. Testicular lymphoma: A population-based study of incidence, clinicopathological correlation and prognosis. The Danish Lymphoma Study Group, Lyfo. Eur J Cancer 1994; 30A: 1760–4.
2. Shabab N, Doll DC. testicular lymphoma. Semin Oncol 1999; 26: 259–69.
3. Ferry JA, Harris NL, Young RH et al. Malignant lymphoma of the testis, epididymis and spermatic cord: a clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994; 18: 376–90.
4. Chan JK, Tsang WY, Lau WH et al. Aggressive T/NK cell lymphoma presenting as testicular tumor. Cancer 1996; 77: 1198–205.
5. Root M, Wang TY, Hescock H et al. Burkitt`s lymphoma of the testucle: report of 2 cases occurring in elderly patients. J Urol 1990; 144: 1239–41.
6. Lagrange JL, Ramaiolli A et al. Non-Hodgkin`s lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centers. Ann Oncol 2001; 12 (9): 1313–9.
7. Darby S, Hancock BW. Localised non-Hodgkin`s lymphoma of the testis: the Sheffield Lymphoma Group experience. Int J Oncol 2005; 26 (4): 1093–9.
8. Fonseca R, habermann TM, Colgan JP. Testicular lymphoma is associate with a high incidence of extranodal recurrence. Cancer 2000; 1; 88 (1): 154–61.
9. Linassier C, Desablens B, Lefranco T et al. Stage I-IIE primary non-Hodgkin`s lymphoma of the testis: result of a prospective trial by the GOELAMS Study Group. Clin Lymphoma 2002; 3 (3): 167–72.
10. Pectasides D, Economopoulos T, Kouvatseas G et al. Anthracycline-based chemotherapy of primary non-Hodgkin`s lymphoma of the testis: the hellenic cooperative oncology group experience. Oncology 2000; 58 (4): 286–92.
11. Jaffe ES, Harris NL, Stein H, Vardiman J. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARCPress 2001; p. 175–77.
12. Cheson B, Horning S, Coiffier B et al. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin`s lymphomas. J Clin Oncol 1999; 14 (4): 1244–53.
13. Zucca E, Conconi A, Mughai T, Sarris A. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003; 1, 21 (1): 20–7.
14. Coiffier B, Lepage E et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma: N Engl J Med 2002; 346: 235–42.
15. Feugier P, Virion J, Tilly H. Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab. Annals of Oncology 2004; 15: 129–33.
16. Rubenstein J, Combs D, Rosenberg J. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 2003; 15, 101 (2): 466–8.
17. Batchelor T, Leahy N, Kaufman D. High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin`s lymphoma. Clin Lymphoma 2001; 2 (2): 116–9.
18. Tilly H, Coiffer B. Survival advantage of ACVBP regimen over standart CHOP in the treatment of advanced aggressive non-Hodgkin`s lymphoma (NHL). The LNH 93-5 study. Ann Oncol 2002; 13: 082a.
19. Zouhair A, Damien W, Belkacemi M et al. Outcome and patterns of failure in testicular lymphoma: a multicenter rare cancer network study. Int J Radiat Oncol Biol Phys 2002; 153 (93): 652–6.
20. Hasselblom S, Ridell B, Wedel H et al. Testicular lymphoma – a retrospective, population-based, clinical and immunohistochemical study. Acta Oncol 2004; 43 (8): 758–65.
21. Horstmann WG, Timens W. Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behavior.
22. Hylant J, Lasota J, Jasinsky M et al. Molecular pathological analysis of testicular diffuse large cell lymphoma. Hum Pathol 1998; 29 (11): 1231–9.
2. Shabab N, Doll DC. testicular lymphoma. Semin Oncol 1999; 26: 259–69.
3. Ferry JA, Harris NL, Young RH et al. Malignant lymphoma of the testis, epididymis and spermatic cord: a clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 1994; 18: 376–90.
4. Chan JK, Tsang WY, Lau WH et al. Aggressive T/NK cell lymphoma presenting as testicular tumor. Cancer 1996; 77: 1198–205.
5. Root M, Wang TY, Hescock H et al. Burkitt`s lymphoma of the testucle: report of 2 cases occurring in elderly patients. J Urol 1990; 144: 1239–41.
6. Lagrange JL, Ramaiolli A et al. Non-Hodgkin`s lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centers. Ann Oncol 2001; 12 (9): 1313–9.
7. Darby S, Hancock BW. Localised non-Hodgkin`s lymphoma of the testis: the Sheffield Lymphoma Group experience. Int J Oncol 2005; 26 (4): 1093–9.
8. Fonseca R, habermann TM, Colgan JP. Testicular lymphoma is associate with a high incidence of extranodal recurrence. Cancer 2000; 1; 88 (1): 154–61.
9. Linassier C, Desablens B, Lefranco T et al. Stage I-IIE primary non-Hodgkin`s lymphoma of the testis: result of a prospective trial by the GOELAMS Study Group. Clin Lymphoma 2002; 3 (3): 167–72.
10. Pectasides D, Economopoulos T, Kouvatseas G et al. Anthracycline-based chemotherapy of primary non-Hodgkin`s lymphoma of the testis: the hellenic cooperative oncology group experience. Oncology 2000; 58 (4): 286–92.
11. Jaffe ES, Harris NL, Stein H, Vardiman J. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARCPress 2001; p. 175–77.
12. Cheson B, Horning S, Coiffier B et al. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin`s lymphomas. J Clin Oncol 1999; 14 (4): 1244–53.
13. Zucca E, Conconi A, Mughai T, Sarris A. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003; 1, 21 (1): 20–7.
14. Coiffier B, Lepage E et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma: N Engl J Med 2002; 346: 235–42.
15. Feugier P, Virion J, Tilly H. Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab. Annals of Oncology 2004; 15: 129–33.
16. Rubenstein J, Combs D, Rosenberg J. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 2003; 15, 101 (2): 466–8.
17. Batchelor T, Leahy N, Kaufman D. High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin`s lymphoma. Clin Lymphoma 2001; 2 (2): 116–9.
18. Tilly H, Coiffer B. Survival advantage of ACVBP regimen over standart CHOP in the treatment of advanced aggressive non-Hodgkin`s lymphoma (NHL). The LNH 93-5 study. Ann Oncol 2002; 13: 082a.
19. Zouhair A, Damien W, Belkacemi M et al. Outcome and patterns of failure in testicular lymphoma: a multicenter rare cancer network study. Int J Radiat Oncol Biol Phys 2002; 153 (93): 652–6.
20. Hasselblom S, Ridell B, Wedel H et al. Testicular lymphoma – a retrospective, population-based, clinical and immunohistochemical study. Acta Oncol 2004; 43 (8): 758–65.
21. Horstmann WG, Timens W. Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behavior.
22. Hylant J, Lasota J, Jasinsky M et al. Molecular pathological analysis of testicular diffuse large cell lymphoma. Hum Pathol 1998; 29 (11): 1231–9.
Авторы
Г.С.Тумян, А.М.Ковригина, О.Л.Тимофеева, Н.А.Пробатова, Е.Н.Шолохова, Н.Н.Тупицын, И.В.Поддубная, Д.Ш.Османов
ГУ РОНЦ им. Н.Н.Блохина РАМН, Москва
ГУ РОНЦ им. Н.Н.Блохина РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.